Share Email Print

Proceedings Paper

Lesion-specific laser catheters for angioplasty
Author(s): Douglas Murphy-Chutorian
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Since no one laser catheter can treat all types of disease, a new family of 'lesion-specific' devices was evaluated with a holmium laser source. Fifty patients (avg. 69 yrs) with lifestyle-limiting peripheral vascular disease and 29 patients (avg. 58 yrs) with symptomatic coronary disease were studied. Average lesion length was 5.3 cm in legs and 1.5 cm in hearts. A 1.5, 2.0, or 2.8 mm, tapered-tip or non-tapered, multifiber catheter (Eclipse, Palo Alto, CA) was advanced over the wire while emitting 300-1200 mj/pulse at 5 Hz. Mean percent stenosis decreased from 89% to 45% after lasing with a mean of 411 pulses in legs and from 86% to 46% with a mean of 158 pulses in hearts. Complications were infrequent. Laser technical success was 80% and overall procedural success was 97%. Conclusion: 1) Specialized laser catheters delivering holmium laser energy are capable of reducing the severity of peripheral and coronary stenoses including balloon angioplasty failures and bypass graft failures; 2) Follow-up studies are in progress to assess long term efficacy.

Paper Details

Date Published: 1 July 1991
PDF: 5 pages
Proc. SPIE 1420, Optical Fibers in Medicine VI, (1 July 1991); doi: 10.1117/12.43892
Show Author Affiliations
Douglas Murphy-Chutorian, Stanford Univ. (United States)

Published in SPIE Proceedings Vol. 1420:
Optical Fibers in Medicine VI
Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top